{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:19:51Z","timestamp":1788502791156,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":2931,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.breast.2011.04.005","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T10:48:47Z","timestamp":1305888527000},"page":"419-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Surgical management of an Irish cohort of BRCA-mutation carriers"],"prefix":"10.1016","volume":"20","author":[{"given":"Paul A.","family":"Carroll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roisin","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noreen","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"John Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2011.04.005_bib1","series-title":"All Ireland cancer statistics 1998\u20132000","author":"Campo","year":"2004"},{"key":"10.1016\/j.breast.2011.04.005_bib2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.2002.20.4.994","article-title":"BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic","volume":"20","author":"Shih","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.04.005_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jmg.2006.044388","article-title":"Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer","volume":"44","author":"Simard","year":"2007","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.breast.2011.04.005_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.breast.2011.04.005_bib5","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2011.04.005_bib6","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/jnci\/87.22.1681","article-title":"Proportion of breast cancer cases in the United States explained by well-established risk factors","volume":"87","author":"Madigan","year":"1995","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2011.04.005_bib7","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.breast.2011.04.005_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1245\/s10434-007-9612-4","article-title":"The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1\/2 mutations","volume":"15","author":"Fatouros","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2011.04.005_bib9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1158\/0008-5472.CAN-03-2970","article-title":"The prognostic implication of the basal-like (cyclin E high\/p27 low\/p53+\/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer","volume":"64","author":"Foulkes","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2011.04.005_bib10","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djg050","article-title":"Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer","volume":"95","author":"Foulkes","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2011.04.005_bib11","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","article-title":"Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer","volume":"26","author":"Atchley","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.04.005_bib12","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrc1457","article-title":"Hallmarks of \u2019BRCAness\u2019 in sporadic cancers","volume":"4","author":"Turner","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.breast.2011.04.005_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.breast.2006.12.003","article-title":"BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study","volume":"16","author":"Musolino","year":"2007","journal-title":"Breast"},{"key":"10.1016\/j.breast.2011.04.005_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-007-9708-3","article-title":"The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified","volume":"110","author":"Li","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2011.04.005_bib15","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2200::AID-CNCR14>3.0.CO;2-S","article-title":"Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women","volume":"85","author":"Noguchi","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2011.04.005_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/annonc\/mdj095","article-title":"Survival and prognostic factors in BRCA1-associated breast cancer","volume":"17","author":"Brekelmans","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2011.04.005_bib17","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1200\/JCO.1999.17.11.3653","article-title":"Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?","volume":"17","author":"Phillips","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.04.005_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ejca.2006.12.009","article-title":"Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1\/2 families as compared to sporadic breast cancer cases","volume":"43","author":"Brekelmans","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2011.04.005_bib19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.breast.2008.03.011","article-title":"Breast cancer outcomes following a national initiative in Ireland to restructure delivery of services for symptomatic disease","volume":"17","author":"de Blacam","year":"2008","journal-title":"Breast"},{"key":"10.1016\/j.breast.2011.04.005_bib20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","article-title":"Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers","volume":"91","author":"Rebbeck","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2011.04.005_bib21","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2011.04.005_bib22","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2011.04.005_bib23","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.04.005_bib24","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ijc.23340","article-title":"International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers","volume":"122","author":"Metcalfe","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2011.04.005_bib25","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","article-title":"Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers","volume":"93","author":"Hartmann","year":"2001","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2011.04.005_bib26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.04.005_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2011.04.005_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjc.6602703","article-title":"Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers","volume":"93","author":"van Sprundel","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2011.04.005_bib29","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(00)02347-3","article-title":"Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation","volume":"355","author":"Meijers-Heijboer","year":"2000","journal-title":"Lancet"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977611000956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977611000956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:27:46Z","timestamp":1760776066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977611000956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0960977611000956"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2011.04.005","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical management of an Irish cohort of BRCA-mutation carriers","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2011.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}